CompaniesByCap
AQST
Aquestive Therapeutics Inc. (AQST)
NASDAQ

Aquestive Therapeutics Inc. Income Statement 2017–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Revenues
Revenue44.5M57.6M50.6M47.7M50.8M45.8M52.6M67.4M66.9M
Gross Profit26.0M39.7M29.8M28.3M32.9M32.2M
Profitability
Operating Income-71.1M-30.8M-15.1M-42.1M-34.7M-42.9M-52.7M-48.9M-113,000
EBITDA-70.5M-30.1M-13.8M-39.7M-31.7M-39.5M-49.8M-45.7M3.6M
Net Income-83.8M-44.1M-7.9M-54.4M-70.5M-55.8M-66.2M-61.4M-8.9M
Per Share Data
EPS (diluted)
Shares Outstanding (dil.)107M87M61M49M38M34M34M25M

Aquestive Therapeutics Inc. Income Statement — FAQ

Aquestive Therapeutics Inc. (AQST) income statement over the last 9 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see AQST's income statement history?

The chart and table above show Aquestive Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.